InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.85
(
1.06%
)
Bitcoin
69,875.97
(
1.99%
)
Post# of 251943
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 14
Posts 3812
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: DewDiligence post# 244968

Friday, 01/06/2023 9:50:19 AM

Friday, January 06, 2023 9:50:19 AM

Post# of 251943
FATEJNJ - Market non-reaction in other iNK related companies suggest that this is a company specific issue. The upfront was hohum, but the complete funding of all activities related to target antigens must have been the problem. JNJ either must not like the results and/or felt that they were getting milked. IMO the general perspective prior to this was that FATE was the leader in iNK. Others try to avoid them by doing iNKT, iGammaDelta, iMO, etc.... IMO the whole iPSC immune cell space is under a cloud.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up